ImmunityBio, Inc. (IBRX)
Recent Filing Index
| Form | Filed | Qtr End | F_Period | 8K: Earnings Release |
|---|---|---|---|---|
| 10-QLatest | Q2-2026 | 8-K (2026-08-04) · 99.1 | ||
| 10-Q | Q1-2026 | 8-K (2026-05-07) · 99.1 | 8-K (2026-04-09) · 99.1 | ||
| 10-KLatest | FY-2025 | 8-K (2026-02-23) · 99.1 | 8-K (2026-01-15) · 99.1 | ||
| 10-Q | Q3-2025 | 8-K (2025-11-05) · 99.1 | ||
| 10-Q | Q2-2025 | 8-K (2025-08-05) · 99.1 | 8-K (2025-07-25) · 99.1 · 99.2 | ||
| 10-Q | Q1-2025 | 8-K (2025-05-12) · 99.1 | 8-K (2025-04-15) · 99.1 | ||
| 10-K | FY-2024 | 8-K (2025-03-03) · 99.1 | ||
| 10-Q | Q3-2024 | 8-K (2024-11-12) · 99.1 | ||
| 10-Q | Q2-2024 | — | ||
| 10-Q | Q1-2024 | — | ||
| 10-K | FY-2023 | — | ||
| 10-Q | Q3-2023 | — |
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Cover Page | ||
| Audit Information | — |
|
| Statements | ||
| Consolidated Balance Sheets | ||
| Consolidated Balance Sheets (P) | ||
| Consolidated Statements of Operations | ||
| Consolidated Statements of Comprehensive Loss | ||
| Consolidated Statements of Stockholders' Deficit | ||
| Condensed Consolidated Statements of Stockholders' Deficit (unaudited) (P) | — |
|
| Consolidated Statements of Cash Flows | ||
| Consolidated Statements of Stockholders' Deficit Parenthetical) | — |
|
| Notes | ||
| Collaboration and License Agreements and Acquisition | ||
| Commitments and Contingencies | ||
| Cybersecurity Risk Management and Strategy Disclosure | — |
|
| Description of Business | ||
| Earnings Per Share | ||
| Employee Benefits | — |
|
| Fair Value Measurements | ||
| Financial Instruments | ||
| Financial Statement Details | ||
| Goodwill and Intangible Assets, Net | ||
| Income Taxes | ||
| Insider Trading Arrangements | ||
| Insider Trading Policies and Procedures | — |
|
| Inventories | ||
| Lease Arrangements | ||
| License Agreement | — |
|
| Pay Vs Performance Disclosure | ||
| Property, Plant and Equipment, Net | ||
| Related-party Agreements | ||
| Related-party Debt | ||
| Revenue Interest Purchase Agreement | ||
| Revenues | ||
| Segment Information | ||
| Stock-based Compensation | ||
| Stockholders Deficit | ||
| Subsequent Events | ||
| Summary of Significant Accounting Policies | ||
| Warrant Liabilities | ||